Cooperation with China boosts Zimbabwe’s agriculture sector
Victory Capital Management Inc. bought a new stake in Astrana Health, Inc. ( NASDAQ:ASTH – Free Report ) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 44,806 shares of the company’s stock, valued at approximately $2,596,000. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC acquired a new position in Astrana Health in the third quarter valued at $34,000. Nisa Investment Advisors LLC acquired a new position in Astrana Health in the third quarter valued at $35,000. Central Pacific Bank Trust Division acquired a new position in Astrana Health in the third quarter valued at $160,000. Everence Capital Management Inc. acquired a new position in Astrana Health in the third quarter valued at $272,000. Finally, Granite Bay Wealth Management LLC acquired a new position in Astrana Health in the third quarter valued at $290,000. Institutional investors and hedge funds own 52.77% of the company’s stock. Astrana Health Stock Performance NASDAQ:ASTH opened at $42.11 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health, Inc. has a one year low of $32.32 and a one year high of $63.20. The business’s 50-day simple moving average is $54.17 and its 200 day simple moving average is $47.80. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of 32.39, a price-to-earnings-growth ratio of 1.95 and a beta of 1.24. Wall Street Analyst Weigh In A number of brokerages recently weighed in on ASTH. Robert W. Baird lifted their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. KeyCorp initiated coverage on Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Truist Financial boosted their price objective on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Stifel Nicolaus boosted their price objective on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Finally, BTIG Research boosted their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $65.17. Get Our Latest Stock Report on ASTH About Astrana Health ( Free Report ) Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. Further Reading Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. ( NASDAQ:ASTH – Free Report ). Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter .
LOS ANGELES (AP) — Adrian Kempe and Quinton Byfield scored in the second period, and the Los Angeles Kings beat the Seattle Kraken 2-1 on Saturday. David Rittich made 19 saves for the Kings, who improved to 6-2-1 at home. Kempe and Byfield scored 1:44 apart in the second period. Byfield buried a sharp-angle slap shot on a power play while dropping to a knee. It was his 98th career point in 200 games. Brandon Montour got the Kraken on the board with 1:26 left in the game. He converted a long shot with Joey Daccord off for another skater, but Los Angeles held on. Daccord finished with 19 stops for Seattle. Kraken: Jordan Eberle will miss at least three months after undergoing surgery on his pelvis. He had six goals and five assists in 17 games before he got hurt against Chicago on Nov. 14. Kings: The power play had been in a 1-for-16 rut (6.25%) over the previous six games before Byfield found the net. It was the Kings' lone opportunity with the man-advantage. After following its 1-0 loss to Buffalo on Wednesday with a fourth straight period of extreme low-event hockey, Los Angeles created a lot more activity and offense to start the second and generate its two goals. The Kings know how to close out games, improving to 9-0-1 when leading after two periods. The Kraken visit Anaheim on Monday, and the Kings play at San Jose on Monday. AP NHL: https://apnews.com/hub/nhlHail Flutie: BC celebrates 40th anniversary of Miracle in Miami
Canada Carbon (CVE:CCB) Stock Price Down 33.3% – Here’s What Happened
Why IonQ, Applovin, and BigBear.ai Dropped Like a Rock This WeekASUS is cooking up its new ROG NUC pre-built PCs for CES 2025, with a new tease that the next-gen Mini-PC will feature Intel's new Core Ultra 200H "Arrow Lake-H" CPUs and NVIDIA's new GeForce RTX 50 series "Blackwell" GPUs. In a new leak on Chinese social media platform Weibo, we get some sneaky photos of the next-gen ASUS ROG NUC system, which from the outside doesn't look all that different. ASUS is baking in all of the changes inside of the new ROG NUC, where we'll see the use of Intel's new Core Ultra 200H series CPU, and NVIDIA's next-gen GeForce RTX 50 series GPU. We should see ASUS using the flagship Core Ultrra 9 285H processor, as the current-gen ROG NUC (more details on that in the link below) features the flagship Core Ultra 9 185H "Meteor Lake" processor. The new ROG NUC will feature an RTX 50 series GPU -- expect to see the RTX 5070 or RTX 5060 -- while the current-gen ROG NUC rolled out with up to the RTX 4070 inside. On the outside, we can see that there will be 1 x USB Type-C port, 2 x USB Type-A ports, an audio jack, and the power button. The inclusion of a USB-C port is nice to see, as the current-gen ASUS ROG NUC doesn't have USB-C. ASUS is expected to unveil its next-gen ROG NUC at CES 2025, which is just over a week away from now. We'll be at the show, and will give you the full skinny on this powerful new Mini-PC system.Byfield scores in 200th career game as Kings hold off Kraken for 2-1 win